scholarly journals A novel approach for effective superior vena cava isolation using the CARTO electroanatomical mapping system

2021 ◽  
Author(s):  
Dai Inagaki ◽  
Seiji Fukamizu ◽  
Sayuri Tokioka ◽  
Takashi Kimura ◽  
Masao Takahashi ◽  
...  
2004 ◽  
Vol 43 (5) ◽  
pp. A149
Author(s):  
Martin D Lowe ◽  
Laurie A Peterson ◽  
Kristi H Monahan ◽  
Samuel J Asirvatham ◽  
Douglas L Packer

2020 ◽  
Vol 6 (9) ◽  
pp. 596-600
Author(s):  
Tomoyuki Arai ◽  
Seiji Fukamizu ◽  
Sayuri Tokioka ◽  
Takeshi Kitamura ◽  
Rintaro Hojo

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
F Spies ◽  
A Madaffari ◽  
G Voellmin ◽  
P Krisai ◽  
N Schaerli ◽  
...  

Abstract Background/Introduction Extra pulmonary vein (PV) foci may trigger AF recurrence after an initially successful PVI. Superior vena cava (SVC) catheter ablation (CA) may therefore offer a treatment target in order to improve success rates. Purpose The purpose of this study was to evaluate the potential benefit of empirical SVC isolation in addition to PVI in patients undergoing a second CA after index PVI. Methods We retrospectively analyzed consecutive patients scheduled for a second CA because of a recurrence of symptomatic AF. Redo-CA was performed with a 3D electroanatomic mapping system and point-by-point ablation using RF energy in the range between 25 W and 30 W. In case of persistent isolation of all PVs, only SVCI was performed. In case of reconnection of vein(s), a wider antral re-isolation was performed. Redo-PVI (PVI-group) or Redo-PVI plus SVC isolation (SVCI) (PVIplusSVCI-group) were performed at the discretion of the operator. No additional targets were allowed. The endpoint of all procedures was elimination of the PV signals confirmed by a circular mapping catheter at the level of the PV ostium and elimination of all signals in the SVC in case of SVCI. Recurrence of AF during a follow-up of 12 months is presented. Results We analyzed 191 patients (age 61±10 years, 30% female, BMI 27±5 kg/m2, LVEF 56±9%, PLAX 41±7 mm, paroxysmal 61%). Whereas 148 (78%) patients underwent Redo-PVI only, 31 patients (16%) underwent PVI plus SVCI, and in 12 patients (6%) SVCI only was performed. Baseline characteristics did not differ significantly between the two groups. In the PVI-group, 79% were recurrence-free compared to 65% (see Kaplan-Meier curve: log rank p=0.011) in the PVIplusSVCI-group. The RF time of the PVI group focusing on the wide antral re-isolation of vein(s) was significantly higher than for the PVIplusSVCI-group (819±494 s versus 458±444 s; p<0.001). Conclusion Additional empirical SVCI at redo-PVI in patients with symptomatic AF recurrence does not lead to an increase in freedom from AF recurrence. Focusing on an additional “wider antral” re-isolation may be more effective. Kaplan-Meier Survival Curves for Recurre Funding Acknowledgement Type of funding source: None


1961 ◽  
Vol 41 (5) ◽  
pp. 505-508 ◽  
Author(s):  
Richard W. Snodgrass ◽  
Sherman M. Mellinkoff

Sign in / Sign up

Export Citation Format

Share Document